Biomedical Engineering Reference
In-Depth Information
Alden T, Pittman D, Hankins F, Beres E, Engh J, Das S, Hudson S, Kerns K, Kallmes D, Helm G.
In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector
.
Hum Gene Ther 1999;10(13):2245-53.
Alden T, Beres E, Laurent J, Engh J, Das S, London S, Jane J, Hudson S, Helm G.
The use of bone
morphogenetic protein gene therapy in craniofacial bone repair
. J Craniofac Surg 2000;11(1):
24-30.
American Association of Orthopaedic Surgeons.
The Burden of Muscoluskeletal Diseases in the
United States
. In: AAOS Website (Available at:
http://boneandjointburden.org/
) Cited
August 3 2010.
Anderson D, Laquerre S, Goins W, Cohen J, Glorioso J.
Pseudotyping of glycoprotein D-deficient
herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus
attachment and entry
. J Virol. 2000;74(5):2481.
Andrew J, Hoyland J, Andrew S, Freemont A, Marsh D.
Demonstration of TGF-beta 1 mRNA by
in situ hybridization in normal human fracture healing
. Calcif Tissue Int 1993;52(2):74-78.
Aronsohn A, Hughes J.
Nuclear localization signal peptides enhance cationic liposome-mediated
gene therapy
. J Drug Target. 1998;5(3):163-9.
Ashinoff R, Cetrulo C, Galiano R, Dobryansky M, Bhatt K, Ceradini D, Michaels J, McCarthy J,
Gurtner G.
Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis
.
Ann Plast Surg 2004;52(6):585-90.
Aviles M, Lin CH, Zelivyankaya M, Graham J, Boehler R, Messersmith P, Shea L.
The contribu-
tion of plasmid design and release to in vivo gene expression following delivery from cationic
polymer modified scaffolds
. Biomaterials 2010;31:1140-1147.
Bangari D, Mittal S.
Current strategies and future directions for eluding adenoviral vector immu-
nity
. Current Gene Therapy 2006;6(2):215.
Bartlett J, Wilcher R, Samulski R.
Infectious entry pathway of adeno-associated virus and adeno-
associated virus vectors.
J Virol. 2000;74(6):2777.
Bergelson J, Cunningham J, Droguett G, Kurt-Jones E, Krithivas A, Hong J, et al.
Isolation of a
common receptor for coxsackie B viruses and adenoviruses 2 and 5
. Science. 1997;275(5304):
1320.
Betz V, Betz O, Glatt V, Gerstenfeld L, Einhorn T, Bouxsein M, Vrahas M, Evans C.
Healing of
segmental bone defects by direct percutaneous gene delivery: effect of vector dose
. Hum Gene
Ther 2007a;18(10):907-15.
Betz O, Betz V, Nazarian A, Egermann M, Gerstenfeld L, Einhorn T, Vrahas M, Bouxsein M,
Evans C.
Delayed administration of adenoviral BMP-2 vector improves the formation of bone
in osseous defects
. Gene Therapy 2007b; 14:1039-1044.
Blumenthal R, Seth P, Willingham M, Pastan I.
pH-dependent lysis of liposomes by adenovirus
.
Biochemistry. 1986;25:2231-2237.
Bonadio J, Smiley E, Patil P, Goldstein S.
Localized, direct plasmid gene delivery in vivo:
prolonged therapy results in reproducible tissue regeneration
. Nature Medicine 1999;5(7):
753-759.
Bourque W, Gross M, Hall B.
Expression of four growth factors during fracture repair
. Int J Dev
Biol 1993;37:573-579.
Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP.
A versatile
vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine
.
Proc Natl Acad Sci USA 1995;92:7297-7301.
Branden L, Mohamed A, Smith C.
A peptide nucleic acid-nuclear localization signal fusion that
mediates nuclear transport of DNA
. Nat Biotechnol. 1999;17:784-7.
Bright C, Park YS, Sieber AN, Kostuik JP, Leong KW.
In vivo evaluation of plasmid DNA encod-
ing OP-1 protein for spine fusion
. Spine 2006;31:2163.
Brunner S, Sauer T, Carotta S, Cotton M, Saltik M, Wagner E.
Cell cycle dependence of gene
transfer by lipoplex, polyplex and recombinant adenovirus
. Gene Therapy 2000;7:401-407.
Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK.
Vesicular stomatitis virus G glycopro-
tein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer
into mammalian and nonmammalian cells.
1993;90:8033-8037.
Search WWH ::
Custom Search